Feasibility Trial for a Right Ventricular Failure Platform Trial

NCT06570473 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Right Ventricular Dysfunction
Right Heart Failure

Interventions

DRUG: Empagliflozin
DRUG: Ranolazine

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]